VANTA (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces changes to securities under Short Term Additional Surveillance Measure framework effective November 11, 2025, including 11 new … | |||||||||||||||
BSE announces changes to securities under Short Term Additional Surveillance Measure framework effective November 11, 2025, including 11 new additions and 2 removals.
| |||||||||||||||
BSE announces revision of price bands for 36 securities effective November 10, 2025, with bands ranging from 1% to 20%. | |||||||||||||||
BSE announces revision of price bands for 36 securities effective November 10, 2025, with bands ranging from 1% to 20%.
| |||||||||||||||
8,00,000 equity shares of Vanta Bioscience Limited issued on preferential basis to promoters listed and permitted to trade from October 17, … | |||||||||||||||
8,00,000 equity shares of Vanta Bioscience Limited issued on preferential basis to promoters listed and permitted to trade from October 17, 2025.
| |||||||||||||||
8,00,000 equity shares of Vanta Bioscience Limited issued at Rs. 50/- to promoters on preferential basis listed on BSE with effect from … | |||||||||||||||
8,00,000 equity shares of Vanta Bioscience Limited issued at Rs. 50/- to promoters on preferential basis listed on BSE with effect from October 17, 2025.
| |||||||||||||||
Vanta Bioscience Limited has listed 8,00,000 new equity shares issued on preferential basis to promoters, with trading commencing October … | |||||||||||||||
Vanta Bioscience Limited has listed 8,00,000 new equity shares issued on preferential basis to promoters, with trading commencing October 17, 2025.
| |||||||||||||||